Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John R Atack

Showing results (21-30 of 97) with videos related to

Pageof 10
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|January 13, 2005
Different GABAA receptor subtypes mediate the anxiolytic, abuse-related, and motor effects of benzodiazepine-like drugs in primatesJames K Rowlett, Donna M Platt, Snjezana Lelas, et al.
British Journal of Pharmacology|September 27, 2005
Selective labelling of diazepam-insensitive GABAA receptors in vivo using [3H]Ro 15-4513Luanda J Pym, Susan M Cook, Thomas Rosahl, et al.
Neuropharmacology|July 6, 2005
In vivo labelling of alpha5 subunit-containing GABA(A) receptors using the selective radioligand [(3)H]L-655,708John R Atack, Luanda Alder, Susan M Cook, et al.
Neuropharmacology|May 16, 2006
Comparison of in vivo and ex vivo [3H]flumazenil binding assays to determine occupancy at the benzodiazepine binding site of rat brain GABAA receptorsJennifer Li, Rebecca L Fish, Susan M Cook, et al.
Acta Crystallographica. Section D, Structural Biology|October 6, 2018
The X-ray structure of human calbindin-D28K: an improved modelJames W Noble, Rehab Almalki, S Mark Roe, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 2009
Reducing abuse liability of GABAA/benzodiazepine ligands via selective partial agonist efficacy at alpha1 and alpha2/3 subtypesNancy A Ator, John R Atack, Richard J Hargreaves, et al.
Neuroscience Letters|May 21, 2024
Basmisanil, an α5-GABA<sub>A</sub>R negative allosteric modulator, produces rapid and sustained antidepressant-like responses in male miceFernanda Daher, Narcy A Villalobos, Marcus Hanley, et al.
Proteomics|December 13, 2005
Detection of gender differences in rat lens proteins using 2-D-DIGEPaul C Guest, Heather A Skynner, Kamran Salim, et al.
Neuropharmacology|October 19, 2006
L-655,708 enhances cognition in rats but is not proconvulsant at a dose selective for alpha5-containing GABAA receptorsJohn R Atack, Peter J Bayley, Guy R Seabrook, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 4, 2006
Rat pharmacokinetics and pharmacodynamics of a sustained release formulation of the GABAA alpha5-selective compound L-655,708John R Atack, Andy Pike, Ashley Clarke, et al.
Pageof 10

Showing results (21-30 of 97) with videos related to

Sort By:
Pageof 10
Proceedings of the National Academy of Sciences of the United States of America|January 13, 2005
Different GABAA receptor subtypes mediate the anxiolytic, abuse-related, and motor effects of benzodiazepine-like drugs in primatesJames K Rowlett, Donna M Platt, Snjezana Lelas, et al.
British Journal of Pharmacology|September 27, 2005
Selective labelling of diazepam-insensitive GABAA receptors in vivo using [3H]Ro 15-4513Luanda J Pym, Susan M Cook, Thomas Rosahl, et al.
Neuropharmacology|July 6, 2005
In vivo labelling of alpha5 subunit-containing GABA(A) receptors using the selective radioligand [(3)H]L-655,708John R Atack, Luanda Alder, Susan M Cook, et al.
Neuropharmacology|May 16, 2006
Comparison of in vivo and ex vivo [3H]flumazenil binding assays to determine occupancy at the benzodiazepine binding site of rat brain GABAA receptorsJennifer Li, Rebecca L Fish, Susan M Cook, et al.
Acta Crystallographica. Section D, Structural Biology|October 6, 2018
The X-ray structure of human calbindin-D28K: an improved modelJames W Noble, Rehab Almalki, S Mark Roe, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 2009
Reducing abuse liability of GABAA/benzodiazepine ligands via selective partial agonist efficacy at alpha1 and alpha2/3 subtypesNancy A Ator, John R Atack, Richard J Hargreaves, et al.
Neuroscience Letters|May 21, 2024
Basmisanil, an α5-GABA<sub>A</sub>R negative allosteric modulator, produces rapid and sustained antidepressant-like responses in male miceFernanda Daher, Narcy A Villalobos, Marcus Hanley, et al.
Proteomics|December 13, 2005
Detection of gender differences in rat lens proteins using 2-D-DIGEPaul C Guest, Heather A Skynner, Kamran Salim, et al.
Neuropharmacology|October 19, 2006
L-655,708 enhances cognition in rats but is not proconvulsant at a dose selective for alpha5-containing GABAA receptorsJohn R Atack, Peter J Bayley, Guy R Seabrook, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 4, 2006
Rat pharmacokinetics and pharmacodynamics of a sustained release formulation of the GABAA alpha5-selective compound L-655,708John R Atack, Andy Pike, Ashley Clarke, et al.
Pageof 10